Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 22Vitamin D Deficiency 20Prostatic Neoplasms 17Polycystic Ovary Syndrome 10Neoplasms 9Colonic Neoplasms 8Rectal Neoplasms 6Colorectal Neoplasms 6Osteoporosis 5Myelodysplastic Syndromes 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Cardiovascular Diseases 4Warts 3Ovarian Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia 3Brain Neoplasms 3Adenomatous Polyps 3Pathologic Processes 2Pain 2Obesity 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Musculoskeletal Diseases 2Melanoma 2Male Urogenital Diseases 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

Cyclophosphamide 57Cytarabine 44fludarabine phosphate 37Methotrexate 36Whole-Body Irradiation 32Mycophenolic Acid 29Filgrastim 27fludarabine 25Vincristine 22Peripheral Blood Stem Cell Transplantation 22Cyclosporine 20Dexamethasone 19Busulfan 19Specimen Handling 18Methylprednisolone 17venetoclax 16Granulocyte Colony-Stimulating Factor 16Tacrolimus 15Hydrocortisone 15Daunorubicin 15Asparaginase 15merphos 14Mercaptopurine 14Melphalan 14Leucovorin 14Thiotepa 13Cord Blood Stem Cell Transplantation 13Antilymphocyte Serum 13Calcium Dobesilate 12Biopsy 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Cholecalciferol × Clear all
NCT06508099 2024-07-31

VitaStem

St. Petersburg State Pavlov Medical University

Phase 2 Recruiting
220 enrolled
LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡